Australian Clinical Labs (ASX:ACL) Total Liabilities : A$418.7 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Total Liabilities?

Australian Clinical Labs's Total Liabilities for the quarter that ended in Dec. 2023 was A$418.7 Mil.

Australian Clinical Labs's quarterly Total Liabilities declined from Dec. 2022 (A$420.42 Mil) to Jun. 2023 (A$406.24 Mil) but then increased from Jun. 2023 (A$406.24 Mil) to Dec. 2023 (A$418.69 Mil).

Australian Clinical Labs's annual Total Liabilities increased from Jun. 2021 (A$392.79 Mil) to Jun. 2022 (A$395.49 Mil) and increased from Jun. 2022 (A$395.49 Mil) to Jun. 2023 (A$406.24 Mil).

Australian Clinical Labs Total Liabilities Historical Data

The historical data trend for Australian Clinical Labs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Total Liabilities Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Total Liabilities

359.60

392.79

395.49

406.24

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial			463.18	395.49	420.42	406.24	418.69

Australian Clinical Labs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Australian Clinical Labs's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	187.925	+	(215.234	+	-1.7763568394003E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	3.083)
	=	406.2

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	578.913	-	172.671
	=	406.2

Australian Clinical Labs's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	189.992	+	(225.26	+	3.441
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	418.7

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	583.723	-	165.03
	=	418.7

Australian Clinical Labs Total Liabilities Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines